Polymerase θ Inhibition Steps on the CGAS Pedal

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2023 Jun 1

PMID 37259920

Authors

Chelsea M Smith

Gaorav P Gupta

Affiliations

Soon will be listed here.

Abstract

Deficiencies in homologous recombination (HR) repair lead to an accumulation of DNA damage and can predispose individuals to cancer. Polymerase theta (Pol θ, encoded by POLQ) is overexpressed by HR-deficient cancers and promotes cancer cell survival by mediating error-prone double-stranded break (DSB) repair and facilitating resistance against poly-ADP ribose polymerase inhibitor treatment. In this issue of the JCI, Oh, Wang, et al. report on the impact of Pol θ inhibition on activation of antitumor immunity. The authors used pancreatic ductal adenocarcinoma (PDAC) cell and mouse models characterized by HR-associated gene alterations and POLQ overexpression. POLQ knockdown showed synthetic lethality in combination with gene mutations involving DNA repair, including BRCA1, BRCA2, and ATM. Notably, Pol θ deficiency or inhibition suppressed tumor growth, increased the accumulation of unrepaired DNA damage, and enhanced T cell infiltration via the cGAS/STING pathway. These findings suggest a broader scope for Pol θ inhibition in HR-deficient cancers.

Citing Articles

Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome.

Palczewski M, Kuschman H, Hoffman B, Kathiresan V, Yang H, Glynn S Nat Commun. 2025; 16(1):1732.

PMID: 39966373 PMC: 11836389. DOI: 10.1038/s41467-025-56928-1.

Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome.

Thomas D, Palczewski M, Kuschman H, Hoffman B, Yang H, Glynn S Res Sq. 2024; .

PMID: 38645113 PMC: 11030528. DOI: 10.21203/rs.3.rs-4131804/v1.

References

Schimmel J, van Schendel R, den Dunnen J, Tijsterman M . Templated Insertions: A Smoking Gun for Polymerase Theta-Mediated End Joining. Trends Genet. 2019; 35(9):632-644. DOI: 10.1016/j.tig.2019.06.001. View

Kamp J, van Schendel R, Dilweg I, Tijsterman M . BRCA1-associated structural variations are a consequence of polymerase theta-mediated end-joining. Nat Commun. 2020; 11(1):3615. PMC: 7368036. DOI: 10.1038/s41467-020-17455-3. View

Dlugosz A, Janecka A . Novobiocin Analogs as Potential Anticancer Agents. Mini Rev Med Chem. 2016; 17(9):728-733. DOI: 10.2174/1389557516666161223155525. View

Ramsden D, Carvajal-Garcia J, Gupta G . Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining. Nat Rev Mol Cell Biol. 2021; 23(2):125-140. DOI: 10.1038/s41580-021-00405-2. View

Hopfner K, Hornung V . Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol Cell Biol. 2020; 21(9):501-521. DOI: 10.1038/s41580-020-0244-x. View

Yousefzadeh M, Wyatt D, Takata K, Mu Y, Hensley S, Tomida J . Mechanism of suppression of chromosomal instability by DNA polymerase POLQ. PLoS Genet. 2014; 10(10):e1004654. PMC: 4183433. DOI: 10.1371/journal.pgen.1004654. View

Yu A, McVey M . Synthesis-dependent microhomology-mediated end joining accounts for multiple types of repair junctions. Nucleic Acids Res. 2010; 38(17):5706-17. PMC: 2943611. DOI: 10.1093/nar/gkq379. View

Pantelidou C, Sonzogni O, De Oliveria Taveira M, Mehta A, Kothari A, Wang D . PARP Inhibitor Efficacy Depends on CD8 T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer. Cancer Discov. 2019; 9(6):722-737. PMC: 6548644. DOI: 10.1158/2159-8290.CD-18-1218. View

Llorens-Agost M, Ensminger M, Le H, Gawai A, Liu J, Cruz-Garcia A . POLθ-mediated end joining is restricted by RAD52 and BRCA2 until the onset of mitosis. Nat Cell Biol. 2021; 23(10):1095-1104. PMC: 8675436. DOI: 10.1038/s41556-021-00764-0. View

10.

Oh G, Wang A, Wang L, Li J, Werba G, Weissinger D . POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling. J Clin Invest. 2023; 133(11). PMC: 10232002. DOI: 10.1172/JCI165934. View

11.

Davies H, Glodzik D, Morganella S, Yates L, Staaf J, Zou X . HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat Med. 2017; 23(4):517-525. PMC: 5833945. DOI: 10.1038/nm.4292. View

12.

Patterson-Fortin J, Jadhav H, Pantelidou C, Phan T, Grochala C, Mehta A . Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer. Nat Commun. 2023; 14(1):1390. PMC: 10011609. DOI: 10.1038/s41467-023-37096-6. View

13.

Heijink A, Stok C, Porubsky D, Manolika E, de Kanter J, Kok Y . Sister chromatid exchanges induced by perturbed replication can form independently of BRCA1, BRCA2 and RAD51. Nat Commun. 2022; 13(1):6722. PMC: 9640580. DOI: 10.1038/s41467-022-34519-8. View

14.

Carvajal-Garcia J, Cho J, Carvajal-Garcia P, Feng W, Wood R, Sekelsky J . Mechanistic basis for microhomology identification and genome scarring by polymerase theta. Proc Natl Acad Sci U S A. 2020; 117(15):8476-8485. PMC: 7165422. DOI: 10.1073/pnas.1921791117. View

15.

Stockley M, Ferdinand A, Benedetti G, Blencowe P, Boyd S, Calder M . Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta. J Med Chem. 2022; 65(20):13879-13891. DOI: 10.1021/acs.jmedchem.2c01142. View

16.

Zhou J, Gelot C, Pantelidou C, Li A, Yucel H, Davis R . A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors. Nat Cancer. 2021; 2(6):598-610. PMC: 8224818. DOI: 10.1038/s43018-021-00203-x. View

17.

Ceccaldi R, Liu J, Amunugama R, Hajdu I, Primack B, Petalcorin M . Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair. Nature. 2015; 518(7538):258-62. PMC: 4415602. DOI: 10.1038/nature14184. View

18.

Wood R, Doublie S . Genome Protection by DNA Polymerase θ. Annu Rev Genet. 2022; 56:207-228. PMC: 10351424. DOI: 10.1146/annurev-genet-072920-041046. View

19.

Mateos-Gomez P, Gong F, Nair N, Miller K, Lazzerini-Denchi E, Sfeir A . Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination. Nature. 2015; 518(7538):254-7. PMC: 4718306. DOI: 10.1038/nature14157. View

20.

Zatreanu D, Robinson H, Alkhatib O, Boursier M, Finch H, Geo L . Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance. Nat Commun. 2021; 12(1):3636. PMC: 8211653. DOI: 10.1038/s41467-021-23463-8. View